⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANGO News
AngioDynamics, Inc.
AngioDynamics to Participate in Upcoming Investor Conferences
businesswire.com
ANGO
Form 8-K
sec.gov
ANGO
AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
businesswire.com
ANGO
AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)
businesswire.com
ANGO
AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect
businesswire.com
ANGO
AngioDynamics to Present at the Goldman Sachs 47 th Annual Global Healthcare Conference
businesswire.com
ANGO
Theromics Appoints Andrew C. Zeringue as Chief Executive Officer
businesswire.com
ANGO
BSX
JNJ
AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer
businesswire.com
ANGO
Form 8-K
sec.gov
ANGO
Form 8-K
sec.gov
ANGO